SynthesisFrontiers in endocrinology2023

Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs.

Eline N M van Vliembergen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.